| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V21614 | GKT136901 | 955272-06-7 | GKT136901 is a novel and potent NOX1/4 inhibitor acting by blocking tumor angiogenesis through a PPARα mediated mechanism and selective scavenging of peroxynitrite (PON). |
|
V3830 | GLX351322 | 835598-94-2 | GLX351322 is a new NOX4 (NADPH oxidase 4) inhibitor which has relative NOX4 selectivity over NOX2 with with an IC50 of 5 μ M inhibiting hydrogen peroxide production from NOX4-overexpressing cells. |
|
V100351 | ML171 analog 1 | 1730-44-5 | ML171 analog 1 (Crop ID: SR-03000000698-1 SID: 57287906) is a NOX1 inhibitor. |
|
V81270 | r8-Gly-Noxa A BH3 | r8-Gly-Noxa A BH3 is a biologically active peptide. | |
|
V144517 | Saikosaponin bk1 | 110352-77-7 | Saikosaponin bk1 is a binding agent and hepatoprotective agent for the NADPH oxidase 5 (NOX5) dehydrogenase domain. |
|
V1904 | Setanaxib (GKT137831) | 1218942-37-0 | Setanaxib (also known as GKT-137831; GTK831) is anovel, specific, potent, orally bioavailable, and dual inhibitor of NADPH oxidase NOX1/NOX4 with Ki of 110 nM and 140 nM, respectively. |